| Latest Forum Topics / Singapore eDev |
|
|
Ausgroup - the train is moving soon
|
|||||
|
oreocookie
Senior |
05-Jul-2020 14:53
|
||||
|
x 0
x 0 Alert Admin |
peace peace.... may all who vested HUAT ah! | ||||
| Useful To Me Not Useful To Me | |||||
|
Superkilat
Elite |
05-Jul-2020 14:32
|
||||
|
x 0
x 0 Alert Admin |
I dun know. I just park the money if i like that stock. Anyway it is my spare money. Dun think too much in research and figures. My rule is greed when it has potential and fear when it moves too fast. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Djsoul80
Master |
05-Jul-2020 13:26
|
||||
|
x 0
x 0 Alert Admin |
And somemore invested buying 5,000,000+ shares... Wow.. I see you very up high man! Level up! 😊
|
||||
| Useful To Me Not Useful To Me | |||||
|
Djsoul80
Master |
05-Jul-2020 13:25
|
||||
|
x 0
x 0 Alert Admin |
Hahaha! Are you a joker? You mean you didn't know how and why you decide to trade on a stock?? You mean you blind and didn't use your brain to think or do any research first before action? Wow.. Bravo Superkilat. Joker of the forum. Trade first then find out why later you invested. Bingo! 😊
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
05-Jul-2020 12:14
|
||||
|
x 0
x 0 Alert Admin |
AMRE has the strong backing from its major shareholders which include two publicly listed companies, Document Security Systems, Inc. (NYSE listed) and Singapore eDevelopment Limited (SGX listed).
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
guards80
Supreme |
05-Jul-2020 12:14
|
||||
|
x 0
x 0 Alert Admin |
Be patience
|
||||
| Useful To Me Not Useful To Me | |||||
|
Superfast
Supreme |
05-Jul-2020 12:12
|
||||
|
x 0
x 0 Alert Admin |
Hmmm.... But stagnant leh.... Up 0.123 ... Pushed. Down.. again... Haixzz
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
05-Jul-2020 12:09
|
||||
|
x 0
x 0 Alert Admin |
See medtecs? May only 100. Now 500
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Superfast
Supreme |
05-Jul-2020 12:07
|
||||
|
x 0
x 0 Alert Admin |
Now only 0.115 leh
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
05-Jul-2020 12:06
|
||||
|
x 0
x 0 Alert Admin |
See here. Nth to with sed?
|
||||
| Useful To Me Not Useful To Me | |||||
|
Acidrxz
Member |
05-Jul-2020 10:17
|
||||
|
x 0
x 0 Alert Admin |
SORRY...3..ipo of medical reit has what to do with Sed? it is just another project of mr chan but nothing to do with Sed rite
|
||||
| Useful To Me Not Useful To Me | |||||
|
SINGKg
Senior |
05-Jul-2020 10:02
|
||||
|
x 0
x 0 Alert Admin |
Target price $2? :) | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Superkilat
Elite |
05-Jul-2020 09:27
|
||||
|
x 0
x 0 Alert Admin |
Now i know why i vested in this liao. One of three is likely to happen within this year. 1. Equivir has clinical sucess. 2 ipo of Impact Bionedical 3. Ipo of American Medical REITs. | ||||
| Useful To Me Not Useful To Me | |||||
|
Alvin2042
Master |
05-Jul-2020 07:17
|
||||
|
x 0
x 0 Alert Admin |
U r wrong and 98mich98 is correct. SeD will only able to hold up to 19.99% of DSS at any time.
SeD current holdings is 18% of DSS to USD46.66m of preference shares in DSS. Only when SeD enlarge its share capital can SeD convert the preference shares to ordinary shares, but with a limit to 19.99% of DSS enlarge capital.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Justice888
Supreme |
05-Jul-2020 00:29
|
||||
|
x 0
x 0 Alert Admin |
From their reply I understand
Global BioMedical to own approximately 78.9% of the total number of common stock of DSS on an enlarged basis. And they will sell the shares so that it will own less than 19.9%
|
||||
| Useful To Me Not Useful To Me | |||||
|
Justice888
Supreme |
05-Jul-2020 00:27
|
||||
|
x 0
x 0 Alert Admin |
I don?t know wat u meant . Anyway I not buying into DSS . Don?t intend to buy shares in USA .
|
||||
| Useful To Me Not Useful To Me | |||||
|
98mich98
Master |
05-Jul-2020 00:07
|
||||
|
x 0
x 0 Alert Admin |
After tge swap deal impact bio is a sub of DSS. What will happen when impact get listed in US? they will be 2 different company? |
||||
| Useful To Me Not Useful To Me | |||||
|
98mich98
Master |
04-Jul-2020 23:46
|
||||
|
x 0
x 0 Alert Admin |
Yes, let say dss is $20 after impact listing news out. SeD can sell dss shares from 19% reduce to 10%. then they convert the bonds to bring the % back to 19%. SeD can take back money |
||||
| Useful To Me Not Useful To Me | |||||
|
Justice888
Supreme |
04-Jul-2020 23:28
|
||||
|
x 0
x 0 Alert Admin |
The max is 78.9% but due to the restrictions of 19.9%.. they can opt to sell off the balance 59% for profits . My understanding correct ?
|
||||
| Useful To Me Not Useful To Me | |||||
|
Justice888
Supreme |
04-Jul-2020 23:26
|
||||
|
x 0
x 0 Alert Admin |
Extract from sgx query on 8th May.
MThe Proposed Share Swap is structured in such a way which allows the Company to continue to capture the growth of Impact BioMedical in the near future through the appreciation in the common stock of DSS. This was disclosed in the announcement made by the Company on 17 March 2020 Announcement. The Convertible DSS Shares are convertible securities of DSS. For illustration purposes and based on the assumption that: a. Global BioMedical does not have any limit to the number of common stock of DSS it can hold at any one time and b)GlobalBioMedicalexerciseitsrightofconversionforall46,868ConvertibleDSSSharesandreceives 231,481,481common stock of DSS, Global BioMedical will hold in aggregate 231,481,481 common stock of DSS, representing approximately 78.9% of the total number of common stock of DSS on an enlarged basis comprising 293,567,580 common stock. In other words, without the 19.9% limit of the number of DSS shares Global BioMedical can hold at any one time, the 14,500,000 DSS shares and the US$46,868,000 worth of perpetual convertible preferred stock (which can be converted at the conversion rate of US$0.216 per DSS share) to be issued to Global BioMedical, taken together, represent a potential for Global BioMedical to own approximately 78.9% of the total number of common stock of DSS on an enlarged basis. Notwithstanding that Global BioMedical cannot hold more than 19.9% of the total number of common stock of DSS at any one time on an enlarged basis after such conversion, the Company intends to capture the growth of Impact BioMedical in the near future by exercising Global BioMedical?s right of conversion and selling such common stock of DSS. In doing so, the Company will receive a return of investment represented by the difference between the conversion price and the then trading price of the common stock of DSS. This return of investment is likely indirectly linked to the growth of Impact BioMedical and has the potential to translate to an increase of the trading price of the common stock of DSS.
|
||||
| Useful To Me Not Useful To Me | |||||

